Tiancheng's pharmacodynamics research system has decades of research experience, formerly known as the "Tianjin Hypertension Pharmacodynamics Laboratory of the New Drug Research Management Center of the State Pharmaceutical Administration" and the "State Key Laboratory of Pharmacokinetics and Pharmacodynamics co built by the Ministry and the Province of Tianjin", two State Key Laboratory. The pharmacodynamics research team has rich research and development experience, proficient in mature modeling techniques for over 300 pharmacodynamic models, especially in the fields of tumor, cardiovascular, neurological, metabolic and other pharmacodynamics research.
Cardiovascular and cerebrovascular diseases
Angina pectoris, myocardial infarction, ischemic heart failure
Acute and chronic
Pulmonary hypertension
Hemorrhagic, ischemic, acute phase, recovery phase, sequelae phase
tumour
Cytotoxicity, Biomarkers, Migration and Invasion
Heterologous transplantation tumor, induced primary tumor, metastatic tumor
Hematological system tumors, lymphatic system tumors
Angiogenesis, differentiation and metastasis, cell cycle, apoptosis, tumor drug resistance, tumor biological response
other
Gastritis, gastric ulcer, excessive stomach acid, inflammatory bowel disease, fatty liver, non-alcoholic fatty liver disease, non viral hepatitis, cirrhosis, liver failure, cholecystitis, pancreatitis
Bronchial asthma, pneumonia, pulmonary fibrosis, pulmonary edema, acute lung injury
Diabetes and various complications, hyperuricemia/gout, hyperlipidemia, osteoporosis
Osteoarthritis, rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, systemic sclerosis, atopic dermatitis
Migraine, spinal cord injury, Alzheimer's disease, depression
Nephritis, renal failure, diabetes nephropathy, premature ovarian failure
Burns, osteonecrosis of the femoral head, ophthalmic diseases, chronic pain